Frank Mottola, SVP, Quality, GMP, Operations, IT at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 15,000 shares at $36.98 ($555K) on 2024-11-07, disclosed to the SEC on 2024-11-08.
Open-market sale of $555k SUPN by SVP, Quality, GMP, Operations, IT. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| SUPN | SELL | 2025-09-15 | $229K | — | Filing → |
| SUPN | SELL | 2025-08-27 | $623K | — | Filing → |
| SUPN | SELL | 2023-11-16 | $31K | — | Filing → |